"Ohio State Havener Eye Institute offers comprehensive vision care. Experts provide vision correction surgery and treat eye issues caused by glaucoma or other nervous system problems."

During the past decade, The Ohio State University, Havener Eye Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "The Ohio State University, Havener Eye Institute" are ""Wet" Age-Related Macular Degeneration" (1 trials), "Diabetic Macular Edema" (1 trials), "Glaucoma, Open-Angle" (1 trials), "Neovascular Age-related Macular Degeneration" (1 trials) and "Ocular Hypertension" (1 trials). Many other conditions were trialed in "The Ohio State University, Havener Eye Institute" in a lesser frequency.

Most popular intervention types in "The Ohio State University, Havener Eye Institute" are "Drug" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Active Comparator: Timolol 0.5%" (1 trials), "Aflibercept" (1 trials) and "Bimatoprost SR" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Ohio State University, Havener Eye Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "The Ohio State University, Havener Eye Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in The Ohio State University, Havener Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in The Ohio State University, Havener Eye Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".